Human urocortin II: Mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide

Brain Research

Volumn 943, Issue 1, 2002, Pages 142-150

  Valdez, Glenn R ^a   Inoue, Koki ^a,b   Koob, George F ^a   Rivier, Jean ^c   Vale, Wylie ^c   Zorrilla, Eric P ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Anxiety like behavior; Corticotropin releasing factor; Locomotor behavior; Stress; Urocortin II

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; IMMOBILIZATION; LIGHT DARK CYCLE; LOCOMOTION; MALE; MAZE TEST; METHODOLOGY; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; STRESS; TIME; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SHEEP;

EID: 0037024959     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02707-5     Document Type: Article

References (53)

1. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety
2. Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats
3. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
4. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: Implications for the treatment of CNS disorders
5. Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice
6. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice
7. Central effects of corticotropin releasing factor (CRF): Evidence for similar interactions with environmental novelty and with caffeine
8. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone
9. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test
10. Propranolol antagonizes the enhanced conditioned fear produced by corticotropin releasing factor
11. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1
12. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice
13. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
14. Ethopharmacological analysis of rat behavior on the elevated plus-maze
15. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
16. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses?
17. Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats
18. Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle
19. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone
20. Corticotropin releasing factor mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute stress in the immature rat
21. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior
22. Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor
23. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
24. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
25. Corticotropin releasing factor, stress, and behavior
26. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation
27. CRF antagonist partially reverses CRF- and stress-induced effects on feeding
28. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor
29. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain
30. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
31. Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests
32. Involvement of hypothalamic corticotropin-releasing factor neurons in behavioral responses to novelty in rats
33. Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions
34. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
35. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat
36. Corticotropin releasing factor receptors and their ligand family
37. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2
38. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors
39. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2beta-selective antisauvagine-30
40. The effects of ICV-CRH on novelty-induced behavior
41. Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety
42. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
43. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
44. Corticotropin releasing factor produces behavioural activation in rats
45. Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide
46. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety
47. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor
48. Chemical and biological characterization of corticotropin releasing factor
49. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
50. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
51. The role of the lateral septum in anxiolysis